Aster DM Healthcare delivers robust Q4 FY26 performance

Aster DM Healthcare, one of the leading integrated healthcare service providers in India, today announced its financial results for the quarter ended March 31, 2026. Commenting on the performance for Q4 FY26, Dr. Azad Moopen, Founder and Chairman, Aster DM Healthcare, said:

Key Financial Highlights

Aster DM Healthcare for Q4 FY26:

- Revenue for Q4 FY26 grew 18% YoY to INR 1,182 Cr
- Operating EBITDA (ex-Kasaragod) grew 31% YoY to INR 253 Cr in Q4 FY26
- Operating EBITDA Margins (ex-Kasaragod) stood at 21.7% in Q4 FY26 Vs. 19.3% in Q4 FY25
- Normalised PAT1 (ex-Kasaragod) grew 45% YoY to INR 153 Cr In Q4 FY26

Aster + QCIL (Combined Proforma) Performance for Q4 FY26

- Proforma Revenue for Q4 FY26 grew by 18% to INR 2,361 Cr
- Proforma Operating EBITDA grew by 25% to INR 517 Cr
- Proforma Operating EBITDA margin stood at 21.9%
- The merger proposal received overwhelming shareholder approval, with 96.68% of total votes cast in favor.

"We are very pleased that the merger of Aster DM Healthcare and Quality Care India Limited (QCIL), in partnership with Blackstone, is progressing towards completion in Q1 FY 2026-27. The overwhelming shareholder support, with 96.68% votes in favour, reflects strong confidence in our vision of building a scaled and integrated healthcare platform. On a proforma basis, Q4 FY26 revenues grew 18% YoY to INR 2,361 Cr, while operating EBITDA increased 25% YoY to INR 517 Cr, supported by strong growth in patient volumes, and continued margin expansion.

The combined entity will have a capacity of over 10,623 beds across 28 cities, with an additional pipeline of around 4,445 beds, providing clear visibility to exceed 15,500 beds in the near term, thus . This positions the platform to become one of the top three healthcare providers in India."

On Q4 FY26 performance of Aster DM Healthcare Dr. Moopen added, "Our performance this quarter reflects consistent execution, with revenues growing 18% YoY to INR 1,182 Cr. Excluding the impact of the newly commissioned Kasargod facility, operating EBITDA grew 31% YoY, with margins improving to 21.7%, driven by operating leverage and disciplined cost management."

Shares of Aster DM Healthcare Limited was last trading in BSE at Rs. 699.45 as compared to the previous close of Rs. 705.25. The total number of shares traded during the day was 23770 in over 1339 trades.

The stock hit an intraday high of Rs. 714.50 and intraday low of 690.25. The net turnover during the day was Rs. 16587088.00.

Source : Equity Bulls

Keywords

AsterDMHealthcare INE914M01019 HealthcareServices Q4FY26 FY2026 ResultUpdate